2vt5: Difference between revisions

No edit summary
No edit summary
Line 1: Line 1:
{{Seed}}
{{Seed}}
[[Image:2vt5.jpg|left|200px]]
[[Image:2vt5.png|left|200px]]


<!--
<!--
Line 12: Line 12:
===FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE-1-PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH A DUAL BINDING AMP SITE INHIBITOR===
===FRUCTOSE-1,6-BISPHOSPHATASE(D-FRUCTOSE-1,6-BISPHOSPHATE-1-PHOSPHOHYDROLASE) (E.C.3.1.3.11) COMPLEXED WITH A DUAL BINDING AMP SITE INHIBITOR===


<!--
The line below this paragraph, {{ABSTRACT_PUBMED_18650089}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 18650089 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_18650089}}


==About this Structure==
==About this Structure==
2VT5 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VT5 OCA].  
2VT5 is a [[Single protein]] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2VT5 OCA].  
==Reference==
Allosteric FBPase inhibitors gain 10(5) times in potency when simultaneously binding two neighboring AMP sites., Hebeisen P, Kuhn B, Kohler P, Gubler M, Huber W, Kitas E, Schott B, Benz J, Joseph C, Ruf A, Bioorg Med Chem Lett. 2008 Jul 5. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/18650089 18650089]
[[Category: Fructose-bisphosphatase]]
[[Category: Fructose-bisphosphatase]]
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
Line 31: Line 40:
[[Category: Zinc]]
[[Category: Zinc]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Jul 23 11:42:17 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Aug  6 09:54:35 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA